Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology

Leukemia

Volumn 14, Issue 2, 2000, Pages 312-315

  Nakao, M ^b   Janssen, J W G ^c   Seriu, T ^a   Bartram, C R ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Acute lymphoblastic leukemia; LightCycler; N ras; Point mutation

Indexed keywords

DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DEVICE; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TECHNIQUE;

EID: 0033974884     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401645     Document Type: Article

References (22)

1. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-4689.
2. Rodenhuis S, Bos JL, Slater RM, Behrendt H, van 't Veer M, Smets LA. Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood 1986; 67: 1698-1704.
3. Janssen JWG, Steenvoorden AC, Lyons J, Anger B, Böhlke JU, Bos JL, Seliger H, Bartram CR. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 1987; 84: 9228-9232.
4. Neri A, Knowles DM, Greco A, McCormick F, Dalla-Favera R. Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 1988; 85: 9268-9272.
5. Bartram CR, Ludwig WD, Hiddemann W, Lyons J, Buschle M, Ritter J, Harbott J, Fröhlich A, Janssen JWG. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia 1989; 3: 247-256.
6. Bar-Eli M, Ahuja H, Foti A, Cline MJ. N-RAS mutations in T-cell acute lymphocytic leukaemia: analysis by direct sequencing detects a novel mutation. Br J Haematol 1989; 72: 36-39.
7. Lübbert M, Mirro J, Miller CW, Kahan J, Isaac G, Kitchingman G, Mertelsmann R, Herrmann F, McCormik F, Koeffler HP. N-ras gene point mutation in childhood acute lymphoblastic leukemia correlate with a poor prognosis. Blood 1990; 75: 1163-1169.
8. Terada N, Miyoschi J, Kawa-Ha K, Sasai H, Orita S, Yumura-Yagi K, Hara J, Fujinami A, Kakunaga T. Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia. Blood 1990; 75: 453-457.
9. Ahuja HG, Foti A, Bar-Eli M, Cline MJ. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684-1690.
10. Todd AV, Iland HJ. Rapid screening of mutant N-ras alleles by analysis of PCR-induced restriction sites: allele specific restriction analysis (ASRA). Leuk Lymphoma 1991; 3: 293-300.
11. Bashey A, Gill R, Levi S, Farr CJ, Clutterbuck R, Miller JL, Pragnell IB, Marshall CJ. Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implication for the role of N-ras mutation in AML pathogenesis. Blood 1992; 79: 981-989.
12. Yokota S, Nakao M, Horiike S, Seriu T, Iwai T, Kaneko H, Azuma H, Oka T, Takeda T, Watanabe A, Kikuta A, Asami K, Sekine I, Matsushita T, Tsuhciya T, Mimaya J, Koizumi S, Miyake M, Nishikawa K, Takaue Y, Kawano Y, Iwai A, Ishida Y, Matsumoto K, Fujimoto T. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. Int J Hematol 1998; 67: 379-387.
13. Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motoji T, Omoto E, Saito H, Ohno R, Ueda R. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074-3080.
14. Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD, Liu ET. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood 1994; 83: 1603-1611.
15. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler: a microvolume multisample fluorimetrer with rapid temperature control. Biotechniques 1997; 22: 176-181.
16. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997; 245: 154-160.
17. Caplin BE, Rasmussen RP, Bernard PS, Wittwer CT. LightCycler hybridization probes. Biochemica 1999; 1: 5-8.
18. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
19. van Dongen JJ, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731-1738.
20. Janssen JWG, Bartram CR. Silent mutation at codon 15 interferes with the detection of a mutated N-ras codon 12 allele by oligonucleotide hybridization. Leukemia 1989; 3: 235.
21. Cane PA, Cook P, Ratcliffe D, Mutimer D, Pillay D. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob Agents Chemother 1999; 43: 1600-1608.
22. Nauck M, Wieland H, Marz W. Rapid, homogeneous genotyping of the 4G/5G polymorphism in the promoter region of the PAII gene by fluorescence resonance energy transfer and probe melting curves. Clin Chem 1999; 45: 1141-1147.